Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

When developing clinical tools, it's essential to prioritize clinical relevance. Get experienced clinicians involved early in ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Addressing the challenges of fragrance design, researchers have developed an AI model that can automate the creation of new fragrances based on user-defined scent descriptors. The model uses mass ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective.

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

Hassabis also spoke to Reid Hoffman, co-founder of LinkedIn, about the scale and speed at which AI is transforming science. Using DeepMind’s AlphaFold technology, researchers managed to predict the ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...